Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Chinese Journal of Medical Genetics ; (6): 290-294, 2002.
Article in Chinese | WPRIM | ID: wpr-245316

ABSTRACT

<p><b>OBJECTIVE</b>To gain an insight into the relations between human leukocyte antigen-DRB1 (HLA-DRB1) alleles and idiopathic thrombocytopenic purpura (ITP) in children.</p><p><b>METHODS</b>Polymerase chain reaction-sequence specific oligonucleotide (PCR-SSO) was used to identify DRB1 alleles of 42 children with ITP. Among them, 36 were identified for anti-GPIIb/IIIa and anti-GPIb/Ix autoantibody by modified monoclonal antibody specific immobilization of platelet antigens.</p><p><b>RESULTS</b>Compared with health controls, the frequency of HLA-DRB1*17 significantly increased (P<0.05, relative risk=2.76, etiologic factor=0.1064) and the frequency of HLA-DRB1*1202 significantly decreased (P<0.025, relative risk=0.20, prophylactic factor=0.7616) in children with ITP. In comparison with patients of good response to steroids and IVIgG therapy, the frequency of HLA DRB1*11 significantly increased (Chi-square=6.091, P<0.025) in patients with a poor response, furthermore, the most of HLA-DRB1*11 positive patients were female teen-agers. Twenty-seven patients (75%) had anti GPIIb/IIIa and seventeen (47.22%) had anti_GPIb/Ix autoantibodies. The positivities of both anti_GP IIb/IIIa (P=0.02) and anti-GPIb/Ix (P=0.01) were associated with HLA-D RB1*02. However, the positivity of autoantibodies between refractory and non-refractory patients showed no significant difference.</p><p><b>CONCLUSION</b>The allele of HLA-DRB1*17 seems to predict susceptibility of ITP in children, while HLA-DRB1*1202 appears to be protective to ITP. The allele of HLA DRB1*11 plays an important role in resistance to steroid and IgG therapy in children with ITP. It seems that the response to the antigenic epitope of GPIIb/IIIa and GPIb/Ix is restricted by HLA-DRB1*02, while the presence of the antibodies could not predict prognosis. In conclusion, the above preliminary findings indicate that genetic factors influence the clinical course of ITP, but the exact mechanism needs to be investigated further.</p>


Subject(s)
Adolescent , Child , Child, Preschool , Female , Humans , Male , Alleles , Autoantibodies , Blood , DNA , Genetics , Drug Resistance , Genetics , Gene Frequency , Genotype , HLA-DR Antigens , Genetics , HLA-DRB1 Chains , Immunoglobulin G , Therapeutic Uses , Platelet Glycoprotein GPIIb-IIIa Complex , Allergy and Immunology , Platelet Glycoprotein GPIb-IX Complex , Allergy and Immunology , Platelet Membrane Glycoproteins , Purpura, Thrombocytopenic, Idiopathic , Blood , Drug Therapy , Genetics , Steroids , Therapeutic Uses
2.
Chinese Journal of Hematology ; (12): 466-469, 2002.
Article in Chinese | WPRIM | ID: wpr-261381

ABSTRACT

<p><b>OBJECTIVE</b>To study the relationship between HLA-DRB1 alleles and idiopathic thrombocytopenic purpura (ITP) in children.</p><p><b>METHODS</b>PCR-SSO was used to identify DRB1 alleles of 42 children with ITP. Among them, anti-GPIIb/IIIa and anti-GPIb/IX autoantibody were detected in 36 cases by modified monoclonal antibody specific immobilization of platelet antigens (MAIPA).</p><p><b>RESULTS</b>(1) Compared with healthy controls, HLA-DRB1 * 17 was significantly increased (relative risk = 2.76, P < 0.05, etiologic factor = 0.106 4) and HLA-DRB1 * 1202 decreased (relative risk = 0.20, P < 0.025, prophylactic factor = 0.761 6) in children with ITP. (2) In comparison with patients with good response to steroids and IgG therapy, HLA-DRB1 * 11 was significantly increased (P < 0.025) in patients with a poor response, furthermore, most (5/6) of HLA-DRB1 * 11-positive patients were female teen-ager. (3) Twenty-seven patients (75%) had anti-GPIIb/IIIa and seventeen (47.22%) had anti-GPIb/IX autoantibodies, the positivity rates of both anti-GPIIb/IIIa (P = 0.02) and anti-GPIb/IX (P = 0.01) were associated with HLA-DRB1 * 02. However, the pos./itivity rates of autoantibodies between refractory and non-refractory patients showed no significant difference.</p><p><b>CONCLUSION</b>(1) The DRB1 * 17 seems to predict susceptibility to ITP in children, while DRB1 * 1202 appears to be protective to against ITP. (2) The DRB1 * 11 plays an important role in resistance to steroid and IgG therapy in children with ITP. (3) It seems that the response to the antigenic epitope of GPIIb/IIIa and GPIb/IX is restricted by DRB1 * 02, while the presence of the autoantibodies couldn't predict prognosis. Our preliminary findings indicate that genetic factors influence the clinical course of ITP, but its exact mechanism needs to be further investigated.</p>


Subject(s)
Child , Female , Humans , Male , Alleles , Gene Frequency , HLA-DR Antigens , Genetics , HLA-DRB1 Chains , Purpura, Thrombocytopenic, Idiopathic , Genetics , Allergy and Immunology , Therapeutics
SELECTION OF CITATIONS
SEARCH DETAIL